Characterization of protein kinase C β isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
Retinal neovascularization is a major cause of blindness and requires the activities of several signaling pathways and multiple cytokines. Activation of protein kinase C (PKC) enhances the angiogenic process and is involved in the signaling of vascular endothelial growth factor (VEGF). We have demonstrated a dramatic increase in the angiogenic response to oxygen-induced retinal ischemia in transgenic mice overexpressing PKCβ2 isoform and a significant decrease in retinal neovascularization in PKCβ isoform null mice. The mitogenic action of VEGF, a potent hypoxia-induced angiogenic factor, was increased by 2-fold in retinal endothelial cells by the overexpression of PKCβ1 or β2 isoforms and inhibited significantly by the overexpression of a dominant-negative PKCβ2 isoform but not by the expression of PKC α, δ, and ζ isoforms. Association of PKCβ2 isoform with retinoblastoma protein was discovered in retinal endothelial cells, and PKCβ2 isoform increased retinoblastoma phosphorylation under basal and VEGF-stimulated conditions. The potential functional consequences of PKCβ-induced retinoblastoma phosphorylation could include enhanced E2 promoter binding factor transcriptional activity and increased VEGF-induced endothelial cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, within the TME, PKC beta, another PKC isoform, is a well‐documented effector of the VEGF signaling that promotes angiogenesis and is required for invasiveness in certain tumors, such as pancreatic tumors [122, 123, 124].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [123]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Self-citationKim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
A simplified system for generating recombinant adenoviruses
He, T.-C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,206
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Oxygen-induced retinopathy in the mouse.
Smith, L. E. H., Wesolowski, E., McLellan, A., Kostyk, S. K., D’Amato, R. J., Sullivan, R., & D'Amore, P. A. (1994) · PubMed · Cited by 1,627
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,260
Self-citationAmelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103
Self-citationAiello, L. P., Bursell, S.-E., Clermont, A., Duh, E., Ishii, H., Takagi, C., Mori, F., Ciulla, T. A., Ways, K., Jirousek, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1473 · Cited by 665
Self-citationJiang, Z. Y., Lin, Y.-W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5971 · Cited by 604
Self-citationTakahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Research works printed but not linked: 2
- L E Smith, E Wesolowski, A McLellan, S K Kostyk, R D'Amato, R Sullivan, P A D'Amore Invest Ophthalmol Visual Sci 35, 101–111 (1994).
- T Sakamoto, T Ishibashi, H Kimura, H Yoshikawa, C Spee, M S Harris, D R Hinton, S J Ryan Invest Ophthalmol Visual Sci 36, 1076–1083 (1995).
Cited by
Items 101–170 of 170
Aida, M., Irié, T., Aida, T., & Tachikawa, T. (2005) · Journal of Dental Research · doi:10.1177/154405910508400305 · Cited by 21
“It has been demonstrated that PKC I and II increase VEGF-induced endothelial cell proliferation (Suzuma et al., 2002), and that PKC inhibitor has an anti-angiogenic effect (Teicher et al., 2001).”
BackgroundYamagata, M., Rook, S. L., Sassa, Y., Ronald, C. W., Geraldes, P., Goddard, L., Clermont, A. C., Gao, B., Salti, H. I., Gundel, R. H., et al. (2006) · The FASEB Journal · doi:10.1096/05-5662com · Cited by 21
Self-citationVinik, A. I. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.12.1547 · Cited by 19
“Advanced glycation end products (glucose-modified proteins resulting from hyperglycaemia) were shown to increase vascular permeability via VEGF through reactive oxygen species generation in a rat granulation skin chamber model.”
BackgroundInfluentialProtein kinase C and endothelial dysfunction in select vascular diseases
Kant, S., & Feng, J. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1618343 · Cited by 19
Protein kinase C-beta: An emerging connection between nutrient excess and obesity
Mehta, N., & Mehta, K. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.07.011 · Cited by 19
Kumar, R., Mani, A. M., Singh, N. K., & Rao, G. N. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2522-0 · Cited by 18
Emerging drugs for age-related macular degeneration
Augustin, A. J., & Offermann, I. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.4.725 · Cited by 17
Kondo, T., Hosoya, K., Hori, S., Tomi, M., Ohtsuki, S., & Terasaki, T. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20237 · Cited by 17
“…stimulates production of diacylglycerol and induces ischemia, resulting in activation of PKCbII-p44/ 42 MAPK in retinal endothelial cells, which is also detected in mice with ischemia-induced retinopathy (Aiello et al., 1997; Kampik and Gandorfer, 2000; Poulaki et al., 2002; Suzuma et al., 2002).”
BackgroundNovel agents for diffuse large B-cell lymphoma
Sinha, R., DeJoubner, N. J., & Flowers, C. R. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.565745 · Cited by 17
“PKCb is a critical component of the VEGF signaling pathway which is important in VEGFmediated tumor angiogenesis [78-80].”
Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization
Zhang, H., Hudson, F. Z., Xu, Z., Tritz, R., Rojas, M., Patel, C. B., Haigh, S. B., Bordán, Z., Ingram, D. A., Fulton, D. J., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22588 · Cited by 15
“PKC overexpression, which enhances neurofibromin degradation, increases retinal neovascularization while genetic deletion or pharmacologic inhibition of PKC prevents retinal neovascularization in OIR.(32,33) Suppression of neurofibromin permits VEGF-mediated Ras activation and restoration of neurofibromin expression i…”
BackgroundInfluentialGupta, A., Mohanty, P., & Bhatnagar, S. (2014) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2014.942462 · Cited by 14
Mysiewicz, S. C., North, K. C., Moreira, L. F. P., Odum, S. J., Bukiya, A. N., & Dopico, A. M. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00103.2022 · Cited by 14
Antidiabetic Activity of Curcumin
Wójcik, M., Krawczyk, M., & Woźniak, L. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812019-4.00031-3 · Cited by 14
Barbuch, R. J., Campanale, K. M., Hadden, C. E., Zmijewski, M. J., Yi, P., O'Bannon, D. D., Burkey, J., & Kulanthaivel, P. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007401 · Cited by 14
“Studies have shown that I and II isoform-specific activation of PKC has been implicated in the development and progression of several diabetic microvascular complications, including diabetic retinopathy (Ishii et al., 1996; Suzuma et al., 2002; Yokota et al., 2003; Curtis and Scholfield, 2004).”
BackgroundDiabetic Foot Ulcer Neuropathy, impaired vasculature, and immune responses
Yousif, D., Yousif, Z. B., & Joseph, P. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1003834 · Cited by 13
Aplin, A. C., & Nicosia, R. F. (2016) · Angiogenesis · doi:10.1007/s10456-015-9493-2 · Cited by 14
Nonproliferative and Proliferative Diabetic Retinopathy
Sun, J. K., & Aiello, L. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_24 · Cited by 14
Self-citationKampoli, A., Tousoulis, D., Pallantza, Z., Paterakis, G., Παπαγεωργίου, Ν., Oikonomou, E. K., Miliou, A., Vlachopoulou, A., & Stefanadis, C. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.159 · Cited by 11
Grant, S. K., Tran, P., Zhang, Q., Zou, A., Dinh, D. M., Jensen, J. R., Zhou, S., Kang, X., Zachwieja, J., Lippincott, J., et al. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.029 · Cited by 11
“, endothelin-1), and by impairing nitric oxide release (Park et al., 2000; Suzuma et al., 2002; Das Evcimen and King, 2007; Meier et al., 2007).”
BackgroundMolecular stress and neurovascular injury in the diabetic retina
Guo, C., & Sodhi, A. (2026) · Journal of Clinical Investigation · doi:10.1172/jci200945 · Cited by 10
Ouaret, D., & Larsen, A. K. (2014) · Cell Cycle · doi:10.4161/15384101.2015.945383 · Cited by 10
“PKC bII promotes angiogenesis as an element of the intracellular signaling pathway induced by vascular endothelial cell growth factor (VEGF) via a VEGF VEGFR2/KDR/Flk1 - phospholipase C gamma - PKC b - Raf MEK - MAP kinase pathway(4) as well as by phosphorylation of the retinoblastoma (Rb) protein, as shown by overexp…”
BackgroundPathophysiologic Implications of Angiotensin I-Converting Enzyme as a Mechanosensor: Diabetes
Moskowitz, D. W. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503321827858 · Cited by 10
Novel therapies, including enzastaurin, in the treatment of ovarian cancer
Vergote, I. B. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.900542 · Cited by 10
“PKCb is a key component of the VEGF signaling pathway that is critical in tumor angiogenesis [81,82].”
BackgroundMechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies
HE, Z. (2003) · European Heart Journal Supplements · doi:10.1016/s1520-765x(03)90041-1 · Cited by 10
Basic and Clinical Aspects of Gene Therapy for Retinopathy Induced by Diabetes
Ting, J., & Martin, D. K. (2006) · Current Gene Therapy · doi:10.2174/156652306776359487 · Cited by 9
“The vessel non-perfusion may also cause retina ischemia and hypoxia, which in turns upregulates VEGF expression and increase neovascularisation [Suzuma et al., 2002]; over-express of GLUT-1 glucose transport channel in endothelial cells and increase glucose-induced oxidative stress in these cells [Takagi et al.”
BackgroundUpdate on treatments of diabetic macular edema
Yang, X., Liu, K., & Xu, X. (2009) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.2009.22.021 · Cited by 7
Génétique des complications du diabète : rétinopathie
Taverna, M. J. (2004) · Annales d Endocrinologie · doi:10.1016/s0003-4266(04)95997-5 · Cited by 8
Current and future approaches in the prevention and treatment of diabetic retinopathy
Sarraf, D. (2008) · Clinical ophthalmology · doi:10.2147/opth.s736 · Cited by 10
“…upregulation of the beta-isoform increases retinal vascular permeability and neovascularization (Aiello et al 1997; Xu et al 2004), while inhibition or genetic knockout reduces diabetes-induced retinal permeability and ischemia-induced neovascularization (Danis et al 1998; Suzuma et al 2002).”
Pathogenesis of Diabetic Microvascular Complications
He, Z., Rask‐Madsen, C., & King, G. L. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0901 · Cited by 7
Self-citationOgata, M., & YAMAZAKI, Y. (1979) · PubMed · doi:10.18926/amo/32049 · Cited by 7
Trevino, J. G., Verma, M., Singh, S., Pillai, S., Zhang, D., Pernazza, D., Sebti, S. M., Lawrence, N. J., Centeno, B. A., & Chellappan, S. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0719 · Cited by 6
“This is supported by the studies showing that Raf-1 kinase contributes to angiogenesis (36, 37); this might involve inactivation of Rb with subsequent induction of E2F-1– mediated FLT-1 and KDR transcriptional activation.”
MethodLi, X., Fang, X., Li, S., Zhang, W., Yang, N., Cui, Y., Huang, H., Cai, R., Lin, X., Fu, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7875 · Cited by 6
“It is also a pivotal component in the B-cell receptor and vascular endothelial growth factor (VEGF) signaling pathways, which correlate to B-cell survival and VEGF-induced tumor angiogenesis, respectively [5–8].”
BackgroundProliferative Diabetic Retinopathy
Sun, J. K., Miller, J. W., & Aiello, L. P. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50138-7 · Cited by 6
Self-citationDiabetic macular edema: new trends in management
Shamsi, H. A., & Ghazi, N. G. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.67 · Cited by 5
Discordant mRNA and protein expression of CXCR4 under in vitro CoCl2-induced hypoxic conditions
Tang, M., Yang, Y., Yu, J., Wu, N., Chen, P., Xu, L., Wang, Q., Xu, Z., Ge, J., Yu, K., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.102 · Cited by 5
PKC and Control of the Cell Cycle
Black, J. D. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_8 · Cited by 7
Role of HIF1α and PKCβ in mediating the effect of oxygen and glucose in a novel wound assay
Gadad, P. C., Matthews, K. H., & Knott, R. M. (2013) · Microvascular Research · doi:10.1016/j.mvr.2013.03.008 · Cited by 7
Dietary fat/cholesterol-sensitive PKCβ-RB signaling: Potential role in NASH/HCC axis
Huang, W., Mehta, D., Sif, S., Kent, L. N., Jacob, S. T., Ghoshal, K., & Mehta, K. D. (2017) · Oncotarget · doi:10.18632/oncotarget.17890 · Cited by 4
“PKCβ is reported to phosphorylate retinoblastoma (RB) in vitro [20].”
BackgroundPhysiological and Non-Redundant Functions of PKC Isotypes in T Lymphocytes
Thuille, N., Gruber, T., Pfeifhofer‐Obermair, C., Hermann‐Kleiter, N., Lutz‐Nicoladoni, C., Letschka, T., Kollmann, V., Leitges, M., & Baier, G. (2006) · Current Immunology Reviews · doi:10.2174/157339506776843006 · Cited by 3
Self-citationProtein kinase C inhibition in diabetic retinopathy and microvascular disease
Walton, C., Ryder, R. E. J., & Girach, A. (2007) · Practical Diabetes · doi:10.1002/pdi.1116 · Cited by 3
Das, J. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1124088 · Cited by 3
Kizub, I. V., Oi, K., Kostiuk, O., Остапченко, Л. І., & Soloviev, A. I. (2017) · Regulatory Mechanisms in Biosystems · doi:10.15421/021745 · Cited by 3
“Alternatively, PKC-dependent reduction in eNOS expression has been shown in retinal (Suzuma et al., 2002) and aortic (Hink et al., 2001) endothelial cells in diabetes.”
BackgroundEffects of Diabetes and Insulin Resistance on Endothelial Functions
He, Z., Naruse, K., & King, G. L. (2005) · Humana Press eBooks · doi:10.1385/1-59259-908-7:025 · Cited by 3
“The use of the PKCβ selective inhibitor LY333531 can decrease endothelial cell proliferation, angiogenesis, and permeability induced by VEGF (145,146).”
InfluentialSelf-citationGenetic Manipulation of Protein Kinase C In Vivo
Toker, A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-397-6:475 · Cited by 3
Kobayashi, M., KANAYAMA, K., & Ishida, Y. (2004) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.40.85 · Cited by 2
“…to regulate many pathophysiological functions such as cell proliferation (Murray et al., 1993; Murray et al., 1999), immune response (Leitges et al., 1996), cardiomyophaty response (Wakasaki et al., 1997; Takeishi et al., 1998), and diabetic conditions (Kaneto et al., 2002; Pinton et al., 2002).”
BackgroundNonproliferative and Proliferative Diabetic Retinopathy
Sun, J. K., & Aiello, L. P. (2021) · Springer eBooks · doi:10.1007/978-3-319-90495-5_24-1 · Cited by 2
Self-citationPathogenesis of Microvascular Complications
Khamaisi, M., King, G. L., Park, K., & Li, Q. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_7 · Cited by 2
Self-citationOther Therapeutic Agents for the Treatment of Diabetic Neuropathy
Pittenger, G. L., Pharson, H., Ullal, J., & Vinik, A. I. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-311-0_19 · Cited by 2
“Activation of PKC-β activates MAP kinase and, subsequently, phosphorylation of transcription factors that are involved in angiogenesis, increased stress-related genes, c-Jun kinases and heat shock proteins, all of which can damage cells and vascular endothelial growth factor (VEGF) ( 30 ), which is known to play a cri…”
BackgroundGrewal, B. K., & Sobhia, M. E. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.05.085 · Cited by 2
Regulation of PKC by Protein–Protein Interactions in Cancer
Kim, J., & Mochly‐Rosen, D. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_5 · Cited by 2
Role of Protein Kinase C-iota in Prostate Cancer
Win-Piazza, H. (2008) · Digital Commons - University of South Florida (University of South Florida) · Cited by 2
Synthesis and isozyme selectivity of small molecule protein kinase C inhibitors: a review of patents
Sridhar, J., & Pattabiraman, N. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.12.1691 · Cited by 3
“Transgenic mouse models show that PKCβ is involved in mediating retinal neovascularisation [48].”
BackgroundEffects of Diabetes and Insulin Resistance on Endothelial Functions
Fu, J., Yu, M. G., Li, Q., Park, K., & King, G. L. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_3 · Cited by 2
Self-citationEssayagh, S., Aridi, T. G., Turunen, T., Choi, L. Y., Adam, H., Patel, N., Scali, S. T., Fisher, M. D., Skaf, K., Csizmadia, E., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202500419r · Cited by 1
Kennedy, L. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70269-5 · Cited by 1
Glycosylation Inhibitors, PKC Inhibitors and Related Interventions Against Complications
Soro‐Paavonen, A., & Cooper, M. E. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_20 · Cited by 1
Protein kinase C in the Regulation of Inflammatory Genes iNOS and TTP
Leppänen, T. (2010) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Kim, B. H., Lee, C. W., Park, J. L., Kang, Y. H., Kim, I. J., Kim, Y.-K., & Son, S. M. (2006) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2006.30.6.416 · Cited by 1
Novel Therapeutic Strategies For Posterior Segment Neovascularization
Bingaman, D. P., Gu, X., Timmers, A. M., & Davis, A. A. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6780-8_23
The Role of Protein Kinase C in Diabetic Retinal Vascular Abnormalities
Sun, J. K., & King, G. L. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6780-8_10
Self-citationDiabetic Retinopathy, Inflammation, and Proteasome
Ambrósio, A. F., Pereira, P., & Cunha-Vaz, J. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_22
Luminance flicker-induced retinal vasodilation in humans with and without type 1 diabetes
Noonan, J. E. (2014) · Minerva Access (University of Melbourne)
Pathogenesis of Microvascular Complications
Khamaisi, M., King, G. L., Park, K., & Li, Q. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_7-1
Self-citationOthman, R. (2020) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/30350
Pathogenesis of Microvascular Complications
Khamaisi, M., King, G. L., Park, K., & Li, Q. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_7
Self-citationPathogenesis of Microvascular Complications
Khamaisi, M., King, G. L., Park, K., & Li, Q. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_7-2
Self-citationThe Complex Interplay Between VEGF and Cytokines in the Regulation of Pathological Angiogenesis
Mori, T., Kumar, N., Zhou, W., & Ferrara, N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00226-x
Effekte von LiCl auf den Wnt/beta-Catenin-Signalweg
Knobloch, V. (2015) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.31081
Suvorexant protects from ocular complications of diabetes in db/db mice
Sodhi, R. K., Mahajan, N. S., Abhyankar, S. D., & Bhatwadekar, A. D. (2026) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005476
Evangelisti, C. (2007) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/315
Metadata
- Authors
- Suzuma, K., Takahara, N., Suzuma, I., Isshiki, K., Ueki, K., Leitges, M., Aiello, L. P., & King, G. L.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- King, George L.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-01-22
- Volume
- 99
- Issue
- 2
- Pages
- 721-726
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC117372
- OpenAlex
- W1992451339
- Cited by
- 170
- References
- 33
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 1 · 2021: 7 · 2020: 5 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 3 · 2015: 3 · 2014: 10 · 2013: 8 · 2012: 8
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- National Institutes of Health (5r29ey010827-04, 5r01ey005110-18)
- National Eye Institute (R01 EY5110, EY10827)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- protein kinase C beta, retinoblastoma protein phosphorylation, retinal neovascularization, vascular endothelial growth factor, endothelial cell proliferation, angiogenesis, retinal endothelial cells, hypoxia
- MeSH terms
- Animals, Cattle, Cell Division, Cells, Cultured, DNA-Binding Proteins, Endothelium, Vascular, Isoenzymes, Lymphokines, Mice, Inbred C57BL, Mice, Transgenic, Neovascularization, Pathologic, Phosphorylation, Protein Kinase C, Retinal Vessels, Transcription Factors, Signal Transduction, Retinoblastoma Protein, Endothelial Growth Factors, Mice, Knockout, Cell Cycle Proteins, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, E2F Transcription Factors, Mice, Protein Kinase C beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.